Literature DB >> 26907971

Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review.

Khyati Mittal1, Deepshikha Pande Katare2.   

Abstract

Epidemiological studies have proved that, there are pathophysiological connections between Type 2 Diabetes Mellitus (T2DM) and Alzheimer's disease (AD). Diabetic patients have higher incidences of cognitive impairment and hence they are more at the risk of developing AD. Some of the recent evidences have majorly stated the effects of insulin resistance in the disturbance of various biological processes and signaling pathways. Both hyperglycemia and hypoglycemic conditions contributes in dysfunctioning of cognitive abilities and functions. The present review summarizes the evidences which establish the possible links between the two pathologies on the account of molecular, biochemical and at histopathological level. The information regarding their interactions was collected from different databases and journals. The gathered information will clearly establish the link among the two pathologies and will be helpful in future for the development of drugs for Type 3 Diabetes.
Copyright © 2016 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Shared links; Type 2 diabetes mellitus; Type 3 diabetes

Mesh:

Year:  2016        PMID: 26907971     DOI: 10.1016/j.dsx.2016.01.021

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  41 in total

Review 1.  Insulin resistance and impaired lipid metabolism as a potential link between diabetes and Alzheimer's disease.

Authors:  Joshua A Kulas; Thaddeus K Weigel; Heather A Ferris
Journal:  Drug Dev Res       Date:  2020-02-05       Impact factor: 4.360

2.  Linking Alzheimer's disease and type 2 diabetes: Novel shared susceptibility genes detected by cFDR approach.

Authors:  Xia-Fang Wang; Xu Lin; Ding-You Li; Rou Zhou; Jonathan Greenbaum; Yuan-Cheng Chen; Chun-Ping Zeng; Lin-Ping Peng; Ke-Hao Wu; Zeng-Xin Ao; Jun-Min Lu; Yan-Fang Guo; Jie Shen; Hong-Wen Deng
Journal:  J Neurol Sci       Date:  2017-08-01       Impact factor: 3.181

Review 3.  Dynamics of diabetes and obesity: Epidemiological perspective.

Authors:  Annette Boles; Ramesh Kandimalla; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-24       Impact factor: 5.187

4.  Thymol improves high-fat diet-induced cognitive deficits in mice via ameliorating brain insulin resistance and upregulating NRF2/HO-1 pathway.

Authors:  Hongyan Li; Tingting Qin; Min Li; Shiping Ma
Journal:  Metab Brain Dis       Date:  2016-10-20       Impact factor: 3.584

5.  Sukkari dates seed improves type-2 diabetes mellitus-induced memory impairment by reducing blood glucose levels and enhancing brain cholinergic transmission: In vivo and molecular modeling studies.

Authors:  Vasudevan Mani; Minhajul Arfeen; Hamdoon A Mohammed; Hossam A Elsisi; Sultan Sajid; Yasser Almogbel; Maha Aldubayan; Muralikrishnan Dhanasekaran; Ahmad Alhowail
Journal:  Saudi Pharm J       Date:  2022-03-29       Impact factor: 4.562

6.  Astragaloside IV, a Natural PPARγ Agonist, Reduces Aβ Production in Alzheimer's Disease Through Inhibition of BACE1.

Authors:  Xu Wang; Yue Wang; Jiang-Ping Hu; Song Yu; Bao-Kun Li; Yong Cui; Lu Ren; Li-De Zhang
Journal:  Mol Neurobiol       Date:  2016-03-29       Impact factor: 5.590

7.  Type 2 diabetes mellitus might be a risk factor for mild cognitive impairment progressing to Alzheimer's disease.

Authors:  Wei Li; Tao Wang; Shifu Xiao
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-29       Impact factor: 2.570

8.  Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach.

Authors:  Brenna Cholerton; Laura D Baker; Thomas J Montine; Suzanne Craft
Journal:  Diabetes Spectr       Date:  2016-11

Review 9.  Therapies for Prevention and Treatment of Alzheimer's Disease.

Authors:  J Mendiola-Precoma; L C Berumen; K Padilla; G Garcia-Alcocer
Journal:  Biomed Res Int       Date:  2016-07-28       Impact factor: 3.411

Review 10.  Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases.

Authors:  Masayoshi Takeuchi
Journal:  Diagnostics (Basel)       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.